|
1
|
Backes CH, Markham K, Moorehead P, Cordero
L, Nankervis CA and Giannone PJ: Maternal preeclampsia and neonatal
outcomes. J Pregnancy. 2011:2143652011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dieplinger H: Method for diagnosing
preeclampsia. Patent WO2013000992 A1. Filed June 28, 2012; issued
January 3. 2013.
|
|
3
|
Bernardi F, Guolo F, Bortolin T,
Petronilho F and Dal-Pizzol F: Oxidative stress and inflammatory
markers in normal pregnancy and preeclampsia. J Obstet Gynaecol
Res. 34:948–951. 2008.PubMed/NCBI
|
|
4
|
Berzan E, Doyle R and Brown CM: Treatment
of preeclampsia: Current approach and future perspectives. Curr
Hypertens Rep. 16:4732014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lyall F: Mechanisms regulating
cytotrophoblast invasion in normal pregnancy and pre-eclampsia.
Aust N Z J Obstet Gynaecol. 46:266–273. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kooistra SM and Helin K: Molecular
mechanisms and potential functions of histone demethylases. Nat Rev
Mol Cell Biol. 13:297–311. 2012.PubMed/NCBI
|
|
7
|
Herz HM and Shilatifard A: The JARID2-PRC2
duality. Genes Dev. 24:857–861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pasini D, Cloos PA, Walfridsson J, Olsson
L, Bukowski JP, Johansen JV, Bak M, Tommerup N, Rappsilber J and
Helin K: JARID2 regulates binding of the Polycomb repressive
complex 2 to target genes in ES cells. Nature. 464:306–310. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kinkel SA, Galeev R, Flensburg C, Keniry
A, Breslin K, Gilan O, Lee S, Liu J, Chen K, Gearing LJ, et al:
Jarid2 regulates hematopoietic stem cell function by acting with
polycomb repressive complex 2. Blood. 125:1890–1900. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mejetta S, Morey L, Pascual G, Kuebler B,
Mysliwiec MR, Lee Y, Shiekhattar R, Di Croce L and Benitah SA:
Jarid2 regulates mouse epidermal stem cell activation and
differentiation. EMBO J. 30:3635–3646. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tange S, Oktyabri D, Terashima M, Ishimura
A and Suzuki T: JARID2 is involved in transforming growth
factor-beta-induced epithelial-mesenchymal transition of lung and
colon cancer cell lines. PLoS One. 9:e1156842014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Manceau G, Letouzé E, Guichard C, Didelot
A, Cazes A, Corté H, Fabre E, Pallier K, Imbeaud S, Le
Pimpec-Barthes F, et al: Recurrent inactivating mutations of ARID2
in non-small cell lung carcinoma. Int J Cancer. 132:2217–2221.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lei X, Xu JF, Chang RM, Fang F, Zuo CH and
Yang LY: JARID2 promotes invasion and metastasis of hepatocellular
carcinoma by facilitating epithelial-mesenchymal transition through
PTEN/AKT signaling. Oncotarget. 7:40266–40284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-tie quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Su CL, Deng TR, Shang Z and Xiao Y: JARID2
inhibits leukemia cell proliferation by regulating CCND1
expression. Int J Hematol. 102:76–85. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suga N, Sugimura M, Koshiishi T, Yorifuji
T, Makino S and Takeda S: Heparin/heparan sulfate/CD44-v3 enhances
cell migration in term placenta-derived immortalized human
trophoblasts cells. Biol Reprod. 86:1341–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zou Y, Jiang Z, Yu X, Sun M, Zhang Y, Zuo
Q, Zhou J, Yang N, Han P, Ge Z, et al: Upregulation of long
noncoding RNA SPRY4-IT1 modulates proliferaiton, migraiton,
apoptosis, and netword formation in trophoblast cell HTR-8SV/neo.
PLoS One. 8:e795982013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim YH, Kwon HJ and Kim DS: Matrix
metalloproteinase 9 (MMP-9)-dependent processing of βig-h3 protein
regulates cell migration, invasion, and adhesion. J Biol Chem.
287:38957–38969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Q, Jin M, Yang F, Zhu J, Xiao Q and
Zhang L: Matrix Metalloproteinases: Inflammatory regulators of cell
behaviors in vascular formation and remodeling. Mediators Inflamm.
2013:9283152013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Staun-Ram E, Goldman S, Gabarin D and
Shalev E: Expression and importance of matrix metalloproteinase 2
and 9 (MMP-2 and −9) in human trophoblast invasion. Reprod Biol
Endocrinol. 2:592004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seval Y, Akkoyunlu G, Demir R and Asar M:
Distribution patterns of metalloproteinase (MMP)-2 and-9 and their
inhibitors (TIMP-1 and TIMP-2) in the human decidua during early
pregnancy. Acta Histochem. 106:353–362. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng Q, Dai K, Cui X, Yu M, Yang X, Yan
B, Liu S and Yan Q: Leukemia inhibitory factor promote trophoblast
invasion via urokinase-type plasminogen activator receptor in
preeclampsia. Biomed Pharmacother. 80:102–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jia RZ, Ding GC, Gu CM, Huang T, Rui C,
Wang YX and Lu Q: CDX2 enhances HTR-8/SVneo trophoblast cell
invasion by altering the expression of matrix metalloproteinases.
Cell Physiol Biochem. 34:628–636. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu X, Mu H, Luo X, Xiao X, Ding Y, Yin N,
Deng Q and Qi H: Expression of Gadd45α in human early placenta and
its role in trophoblast invasion. Placenta. 35:370–377. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cudmore MJ, Ahmad S, Sissaoui S, Ramma W,
Ma B, Fujisawa T, Al-Ani B, Wang K, Cai M, Crispi F, et al: Loss of
Akt activity increases circulating soluble endoglin release in
preeclampsia: Identification of inter-dependency between Akt-1 and
heme oxygenase-1. Eur Heart J. 33:1150–1158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bulj Z, Duchi S, Bevilacqua A, Gherardi A,
Dozza B, Piccinini F, Mariani G Adalgisa, Lucarelli E, Giannini S,
Donati D and Marmiroli S: Protein kinase B/AKT isoform 2 drives
migration of human mesenchymal stem cells. Int J Oncol. 42:118–126.
2013.PubMed/NCBI
|
|
27
|
Yoeli-Lerner M and Toker A: Akt/PKB
signaling in cancer: A function in cell motility and invasion. Cell
Cycle. 5:603–605. 2006. View Article : Google Scholar : PubMed/NCBI
|
